Welcome to BioSuperior Insights
Find out more about lung disease and BioSuperior related topics.
RESI investor meetings continue to provide a great platform for startups like BioSuperior Technology
My meetings at the January 2022 RESI Conference were dedicated to introducing BioSuperior Technology. At the June RESi Conference my meetings were a mix of introductions and updates. I was excited to share the progress we have made during the first half of 2022! While...
Insight from NSF I-Corps Program Highlights Critical, Unmet Need In Treating Lung Disease
On their website, the National Science Foundation’s Innovation Corps (I-Corps™) states that their program “uses experiential education to help researchers gain valuable insight into entrepreneurship, starting a business or industry requirements and challenges. I-Corps...
ATS 2022 Confirmed An Exciting Outlook For BioSuperior Technology
Last week’s Research Innovation Summit, which is part of ATS 2022, was a great opportunity to network and learn perspectives from industry experts. I was excited to be there! I looked forward to talking with other companies who are developing lung therapeutics and...